ClinicalTrials.gg
RecruitingNCT06175169Updated Dec 18, 2023

IA Model for Acute Appendicitis in CT

An interventional study of Information of Appendix (IA) model in Acute Appendicitis, sponsored by Hallym University Medical Center. Recruiting at 1 site in Korea, Republic of. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2023-12-18.

Sponsored by Hallym University Medical Center · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Jul 2023, registered Nov 2023).
  • Started Jul 2023; still recruiting 3 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
568
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

the investigators's study group has developed a fully automated 3D convolutional neural network (CNN)-based diagnostic framework using information of appendix (IA) model to identify non-appendicitis and simple and complicated appendicitis on CT scan images based on the two-stage binary classification algorithm, as a clinician does for deciding treatment. The dataset was built from a large population of patients visiting emergency departments who underwent intravenous contrast-enhanced abdominopelvic CT examinations to evaluate abdominal pain in the right or lower quadrant area as the chief complaint. Recently, the IA model was externally validated using a dataset of multicenter institutions through data exfiltration. In this study, the investigators hypothesized that the IA model would show a comparable negative appendicitis rate of \<10% non-inferior margins compared to non-radiologists with a shorter interpretation time in a prospectively randomized dataset.

Read the detailed description

Development of information of appendix model

  • This study used a pretrained information of appendix (IA) model based on a fully automated diagnostic framework to predict three classes with probability and feature mapping: non-appendicitis, simple appendicitis, and complicated appendicitis.

The pipeline of IA model embedding parameters learned from the 3D CT image of 7,147 patients consisted of a two-stage binary algorithm connected to transfer learning with three 3D CNN models: DenseNet, EfficientNet, and ResNet.

  • A two-stage binary algorithm for transfer learning was applied to learn inherent patterns from the 3D images of three true classes, as way a clinician does when deciding treatment for appendicitis. In the first step of the pipeline, a Stage 1 classification model was developed to identify non-appendicitis vs. appendicitis. In the second step of the pipeline, the Stage 2 classification model identified simple vs. complicated appendicitis from the data transferred with the trainable parameters learned in Stage 1.

Currently, the final IA model has been externally validated using a never-before-seen dataset from an outside institution with broad eligibility criteria for patients who visited the emergency room with abdominal pain and underwent abdominopelvic CT due to clinical suspicion of acute appendicitis.

Intervention This is a comparative study between human and IA models for the negative appendectomy rate (NAR) in non-, simple, and complicated appendicitis of a prospective randomized dataset, which was collected from CT scans of patients who visited the emergency room with acute abdominal pain. The participants in the control arm were ten non-radiologists.

The IA model is not allowed to impede the preoperative decision process of clinicians in ongoing clinical practice regarding the legal and ethical aspects of interrogating the diagnostic frameworks of the IA model on the mathematical reasoning for an outcome in terms of protecting human subjects.

Considering the minimal risk to human subjects and the ethical and legal aspects of artificial intelligence, the study design strictly allocates CT images to non-radiologists and IA models after completion of treatment for appendicitis with or without pathologic confirmation.

Data allocation and performance evaluation

  • To compare the IA model to humans and non-radiologists equally, the interpretation condition for a non-radiologist should meet all criteria as follows: Only CT images without such variables as age, sex, and laboratory values should be randomly assigned; affiliation of both the non-radiologist and patient of the CT image should not be the same; the allocation ratio for non-appendicitis, simple, and complicated appendicitis assigned to the non-radiologist should be blinded; and the range of the CT image for interpretation should be identical to the range of the ROI for the appendix, which is generated by automatic localization of the IA model. To evaluate the diagnostic performance in humans, four test items were set up by a non-radiologist as follows: (1) visualization of the appendix; (2) exclusion of appendicitis; (3) complications; and (4) diagnosis of CT images.

The primary and secondary outcomes were assessed using the results of the four questions for the participants and the diagnostic performance of the IA model in the same dataset.

Ethical statement According to the "Guide to Utilizing Healthcare Data" and "Guide to Handling Pseudonym Information" of the Personal Information Protection Commission of the Ministry of Health and Welfare, data exfiltration with security assurance of the data archive was conducted with the approval of the Data Review Board at participating institutions. The central institutional review board (IRB) and IRBs of all participating institutions approved this study.

Sample size and statistical methods The investigators's prior study, which completed external validation of the IA model through data exfiltration of external institutions, showed an NAR of 12.4% in the external dataset. The standard reference value for non-radiologists for NAR has been reported as 10.5% ± 5%. Therefore, the acceptable difference in NAR between the IA model and non-radiologists for clinical application should be less than 10.0% of the non-inferiority margin.

The sample size for the randomized controlled dataset for a single institution was 263 assuming a 95% confidence interval, statistical power of 90%, two-tails sided α = 0.05, significance level = 0.05, and effect size = 0.2 at the Z-test. Two external institutions participated in this study. Due to data heterogeneity, normalization, and prevalence differences across regions between the two external institutions, the sample size was calculated for each institution. Therefore, assuming 263 patients per institution with a follow-up loss of 10%, the total sample size was 568.

02

Conditions studied

  • Acute Appendicitis

Browse trials for

Keywords

  • deep learning
03

In context

Appendicitis

419 studies on the registry are indexed under Appendicitis; 67 are open to participants now.

This study's planned enrollment of 568 is above the median of 111 across 252 interventional studies indexed under Appendicitis.

Browse Appendicitis studies →

Lead sponsor

Hallym University Medical Center is the lead sponsor of 53 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Inclusion criteria for broad eligibility were applied to reflect that the CT utilization rate in the emergency room has rapidly expanded, presumably in many other institutions where physicians maintain a reasonably sensitive standpoint in raising a clinical suspicion of appendicitis as a cause of abdominal pain and then use CT as an imaging test to confirm or rule out appendicitis.

When the imaging protocol parameters were as follows: abdomen or pelvis (intravenous contrast, 2 mg/kg, maximum 160 mL), scan timing (portal venous phase), range (from 4 cm above the liver dome to 1 cm below the ischial tuberosity), radiation dose (tube potential, KVP from 100 to 120), pitch 1.75:1, and reconstruction (5 mm, cut slice for adults; 3 mm, cut slice for children under 12 years old), anonymized CT images of patients were referred to a randomized dataset.

Exclusion criteria

Exclusion Criteria:

Patients who did not fulfill the CT imaging protocol were excluded in detail as follows:

i) Failure to meet the CT protocol criteria of this study: liver CT, biliary CT, etc. (if contrast phase was different); ureter CT, etc. (if contrast media was not used and the reconstruction method was different); non-enhanced CT (when contrast media was not used); and appendix CT or low-dose CT (when radiation dose was low).

ii) When the quality of the CT image is significantly reduced, as follows: when blurring occurs (motion artifact) or metal artifact (when internal fixation is performed due to spinal surgery).

iii) when it was evident from the medical record review that clinical information suggested that APCT was performed due to the suspicion of a condition other than appendicitis, as follows: suspected acute cholecystitis due to RUQ tenderness and Murphy's sign; suspected urolithiasis due to flank pain and gross hematuria; suspected pancreatitis due to a history of pancreatitis; alcohol abuse; and suspected gynecological diseases due to vaginal discharge. Suspected panperitonitis due to whole abdominal tenderness, rebound tenderness, and unstable vital signs. Patients with acute cholecystitis, ureteral stones, pancreatitis, or acute peritonitis due to small bowel or colon perforation were also excluded.

iv) Patients younger than 10 years were excluded. Adolescent patients from 11 to 18 years old were included in the study if the exclusion criteria were not applicable.

v) diagnosed by ultrasound sonography vi) Patients who were transferred to the emergency department after a diagnosis of appendicitis at an outside hospital or ambulatory care were excluded.

vii) Patients with appendicitis who did not undergo surgical treatment because of the enrollment protocol of other ongoing studies.

viii) patients who had undergone an appendectomy

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
568 participants (estimated)

Study arms

  • Active comparator
    IA model

    A fully automated diagnostic framework based on 3D-CNN model to predict non-appendicitis, simple and complicated appendicitis

    Device: Information of Appendix (IA) model

  • No intervention
    Non-radiologist

    Ten non-radiologists participated in this study. CT image same to IA model was allocated to radiologist randomly.

Interventions

  • DeviceInformation of Appendix (IA) model

    Deep learning model

06

What researchers measure

Primary outcomes

  1. Negative appendectomy rate

    Description: False positive rate = FP /FP +TN FP: false positive, TN true negative Assessment of outcomes: To evaluate diagnostic performance in humans, four test items for non-radiologists were set up as follows: (1) Appendix visualization: Can you find the location of the appendix? ① Yes ② No (2) Exclusion of appendicitis: Can appendicitis be excluded from the CT images? ① Yes (non-appendicitis) ② No (simple or complicated appendicitis) (3) If your choice is "no (simple or complicated appendicitis)," is appendicitis accompanied by complication? ① Yes (complicated appendicitis) ② No (simple appendicitis) (4) Finally, what is the radiologic diagnosis based on CT images in patients presenting with acute right or lower abdominal pain in the ER? ① Non-appendicitis ② simple appendicitis ③ complicated appendicitis The NAR was calculated as the primary endpoint using the outcomes of (2) the answer sheet of the non-radiologist and the Stage 1 IA model-yielding class.

    Time frame: Outcome measurement for four test items of non-radiologists will be assessed for an average of one year through study completion.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06175169
Lead sponsor
Hallym University Medical Center
Collaborators
Doheon Institute for Digital Innovation In Medicine, Medical A.I. Center of Hallym University
Responsible party
Iltae Son (Principal Investigator, Hallym University Medical Center) — Principal investigator
First posted
Dec 18, 2023
Start date
Jul 4, 2023
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Dec 18, 2023

Study contacts

Iltae Son
Contact
1tae99@hanmail.net
+82-10-2373-4783
Minsung Kim
Contact
bongkay4@gmail.com
+82-10-2087-9792
Iltae Son
principal investigator · Hallym University Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion